Drug General Information |
Drug ID |
D07IHM
|
Former ID |
DNC008992
|
Drug Name |
CEP-6331
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C27H26N2O3
|
Canonical SMILES |
CC(C)OC1=CC2=C(C=C1)C3=C4C(=C5C6=CC=CC=C6N(C5=C3CC2)CCO<br />)CNC4=O
|
InChI |
1S/C27H26N2O3/c1-15(2)32-17-8-10-18-16(13-17)7-9-20-23(18)25-21(14-28-27(25)31)24-19-5-3-4-6-22(19)29(11-12-30)26(20)24/h3-6,8,10,13,15,30H,7,9,11-12,14H2,1-2H3,(H,28,31)
|
InChIKey |
HSWWFIPPMAFLPH-UHFFFAOYSA-N
|
PubChem Compound ID |
|
Target and Pathway |
Target(s) |
Mitogen-activated protein kinase kinase kinase 11 |
Target Info |
Inhibitor |
[1]
|
Mitogen-activated protein kinase kinase kinase 10 |
Target Info |
Inhibitor |
[1]
|
Mitogen-activated protein kinase kinase kinase 9 |
Target Info |
Inhibitor |
[1]
|
Vascular endothelial growth factor receptor 3 |
Target Info |
Inhibitor |
[1]
|
Fyn tyrosine kinase |
Target Info |
Inhibitor |
[1]
|
Neurotrophic tyrosine kinase receptor 1 |
Target Info |
Inhibitor |
[1]
|
KEGG Pathway
|
MAPK signaling pathway
|
Non-alcoholic fatty liver disease (NAFLD)hsa04014:Ras signaling pathway
|
Rap1 signaling pathway
|
Cytokine-cytokine receptor interaction
|
PI3K-Akt signaling pathway
|
Focal adhesionhsa04071:Sphingolipid signaling pathway
|
Axon guidance
|
Osteoclast differentiation
|
Focal adhesion
|
Adherens junction
|
Platelet activation
|
Natural killer cell mediated cytotoxicity
|
T cell receptor signaling pathway
|
Fc epsilon RI signaling pathway
|
Cholinergic synapse
|
Prion diseases
|
Pathogenic Escherichia coli infection
|
Measles
|
Viral myocarditishsa04010:MAPK signaling pathway
|
Endocytosis
|
Apoptosis
|
Neurotrophin signaling pathway
|
Inflammatory mediator regulation of TRP channels
|
Pathways in cancer
|
Transcriptional misregulation in cancer
|
Thyroid cancer
|
Central carbon metabolism in cancer
|
NetPath Pathway
|
TNFalpha Signaling PathwayNetPath_23:TSH Signaling Pathway
|
IL2 Signaling Pathway
|
TGF_beta_Receptor Signaling PathwayNetPath_14:IL2 Signaling Pathway
|
PANTHER Pathway
|
CCKR signaling map STP00029:Huntington disease
|
p38 MAPK pathwayP00007:Axon guidance mediated by semaphorins
|
Cadherin signaling pathway
|
Integrin signalling pathway
|
Parkinson disease
|
Pathway Interaction Database
|
Reelin signaling pathway
|
CDC42 signaling events
|
IFN-gamma pathway
|
RAC1 signaling pathwayp38_mkk3_6pathway:p38 MAPK signaling pathwayvegf_vegfr_pathway:VEGF and VEGFR signaling network
|
VEGFR3 signaling in lymphatic endotheliumfcer1pathway:Fc-epsilon receptor I signaling in mast cells
|
ErbB4 signaling events
|
Glypican 1 network
|
TCR signaling in naï
|
Signaling events mediated by PTP1B
|
Ephrin A reverse signaling
|
Regulation of p38-alpha and p38-beta
|
TCR signaling in naï
|
Angiopoietin receptor Tie2-mediated signaling
|
Thromboxane A2 receptor signaling
|
Netrin-mediated signaling events
|
IL2-mediated signaling events
|
CXCR4-mediated signaling events
|
Class I PI3K signaling events
|
Posttranslational regulation of adherens junction stability and dissassembly
|
amb2 Integrin signaling
|
EPHA forward signaling
|
E-cadherin signaling in keratinocytes
|
PDGFR-beta signaling pathway
|
Nephrin/Neph1 signaling in the kidney podocyte
|
Signaling events mediated by VEGFR1 and VEGFR2
|
Syndecan-3-mediated signaling events
|
Ephrin B reverse signaling
|
Alpha-synuclein signaling
|
Signaling events mediated by focal adhesion kinasetrkrpathway:Neurotrophic factor-mediated Trk receptor signaling
|
PathWhiz Pathway
|
Fc Epsilon Receptor I Signaling in Mast Cells
|
Reactome
|
VEGF binds to VEGFR leading to receptor dimerizationR-HSA-114604:GPVI-mediated activation cascade
|
PIP3 activates AKT signaling
|
Regulation of KIT signaling
|
Cell surface interactions at the vascular wall
|
FCGR activation
|
PECAM1 interactions
|
Constitutive Signaling by Aberrant PI3K in Cancer
|
DAP12 signaling
|
EPH-Ephrin signaling
|
Role of LAT2/NTAL/LAB on calcium mobilization
|
Nephrin interactions
|
NCAM signaling for neurite out-growth
|
CD28 co-stimulation
|
CD28 dependent PI3K/Akt signaling
|
CD28 dependent Vav1 pathway
|
CTLA4 inhibitory signaling
|
EPHB-mediated forward signaling
|
EPHA-mediated growth cone collapse
|
EPH-ephrin mediated repulsion of cells
|
CRMPs in Sema3A signaling
|
DCC mediated attractive signaling
|
Netrin mediated repulsion signals
|
VEGFA-VEGFR2 Pathway
|
Dectin-2 family
|
CD209 (DC-SIGN) signaling
|
RAF/MAP kinase cascade
|
Platelet Adhesion to exposed collagen
|
Regulation of signaling by CBL
|
Antigen activates B Cell Receptor (BCR) leading to generation of second messengersR-HSA-170968:Frs2-mediated activation
|
ARMS-mediated activation
|
NGF-independant TRKA activation
|
PI3K/AKT activation
|
WikiPathways
|
Insulin SignalingWP481:Insulin Signaling
|
p38 MAPK Signaling PathwayWP1919:Signaling by VEGFWP69:TCR Signaling Pathway
|
Interferon type I signaling pathways
|
IL-2 Signaling Pathway
|
Kit receptor signaling pathway
|
IL-3 Signaling Pathway
|
Ectoderm Differentiation
|
Fc epsilon receptor (FCERI) signaling
|
Signaling by the B Cell Receptor (BCR)
|
Signaling by SCF-KIT
|
DAP12 interactions
|
Host Interactions of HIV factors
|
PIP3 activates AKT signaling
|
T-Cell Receptor and Co-stimulatory Signaling
|
Primary Focal Segmental Glomerulosclerosis FSGS
|
BDNF signaling pathway
|
Interleukin-11 Signaling Pathway
|
B Cell Receptor Signaling Pathway
|
Pathogenic Escherichia coli infection
|
TSLP Signaling Pathway
|
IL-7 Signaling Pathway
|
Leptin signaling pathway
|
Semaphorin interactions
|
Platelet Adhesion to exposed collagen
|
Netrin-1 signaling
|
Nephrin interactions
|
NCAM signaling for neurite out-growth
|
Integrin-mediated Cell Adhesion
|
GPVI-mediated activation cascade
|
Costimulation by the CD28 family
|
Cell surface interactions at the vascular wallWP382:MAPK Signaling Pathway
|
Integrated Pancreatic Cancer Pathway
|
NGF signalling via TRKA from the plasma membrane
|
References |
REF 1 | J Med Chem. 2008 Sep 25;51(18):5680-9. Epub 2008 Aug 21.Mixed-lineage kinase 1 and mixed-lineage kinase 3 subtype-selective dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-5-ones: optimization, mixed-lineage kinase 1 crystallography, and oral in vivo activity in 1-methyl-4-phenyltetrahydropyridine models. |